Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) (Q24240827)

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Inhaled nitric oxide for respiratory failure in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

The existence of publication bias and risk factors for its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Uncertainty method improved on best-worst case analysis in a binary meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Pharmacological therapy for acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Overcoming the limitations of current meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Arcsine test for publication bias in meta-analyses with binary outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Nonventilatory interventions in the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Meta-analysis of rare and adverse event data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

Aerosolized prostacyclin. In search of the ideal pulmonary vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

inferred from DOI database lookup

7 January 2021

based on heuristic

Epidemiology of acute lung injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733

inferred from DOI database lookup

7 January 2021

based on heuristic

Quality-adjusted survival in the first year after the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007733